1
/
of
0
FDA Drug Approval, N208845, ZILRETTA
FDA Drug Approval, N208845, ZILRETTA
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 208845
Company: PACIRA PHARMS INC
Drug Name: ZILRETTA
Active Ingredients: TRIAMCINOLONE ACETONIDE
Strength: 32MG/VIAL
Dosage Form/Route: FOR SUSPENSION, EXTENDED RELEASE;INTRA-ARTICULAR
Action Date: 10/06/2017
Marketing Status: Prescription
Submission Classification: Type 5 - New Formulation or New Manufacturer
Company: PACIRA PHARMS INC
Drug Name: ZILRETTA
Active Ingredients: TRIAMCINOLONE ACETONIDE
Strength: 32MG/VIAL
Dosage Form/Route: FOR SUSPENSION, EXTENDED RELEASE;INTRA-ARTICULAR
Action Date: 10/06/2017
Marketing Status: Prescription
Submission Classification: Type 5 - New Formulation or New Manufacturer
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details